Jack Truman v SPL Powerlines UK Limited & Ors
[2026] EAT 54 · 1 May 2026
Prescribed medical cannabis, a positive workplace drug test and disability discrimination are central to the appeal.
The Reasonable Adjustment · Case law
Medical cannabis in the courts
Decisions concerning prescribed cannabis, medicinal use and cannabis medicines. Each entry explains the connection to medical cannabis and links to the official judgment.
Core cases directly address medical use. Related cases consider it within a wider dispute. The collection includes historical medical-necessity and commercial cases; relevance labels do not indicate precedent or a favourable outcome.
12 decisions · Newest decision first
R, S, T (Perplexing Presentations: Findings and Welfare), Re
[2026] EWFC 194 (B) · 23 April 2026
Legitimately prescribed cannabis, alleged self-medication and its claimed effect on parenting are materially considered in welfare findings.
Bristol City Council v M & Anor
[2026] EWFC 91 (B) · 20 March 2026
Prescribed medicinal cannabis and reduced illicit use form part of the court’s welfare and substance-use assessment.
Hamza Malik v The Registrar of Approved Driving Instructors
[2026] UKFTT 383 (GRC) · 18 March 2026
A recent prescription application and cannabis-based prescriptions form part of the context, but the decision centres on prolonged unlawful supply and fitness to remain an approved driving instructor.
Cefyn Jones v The Information Commissioner
[2026] UKFTT 141 (GRC) · 26 January 2026
Medicinal-cannabis legalisation and alleged policy influence define the information request, while the appeal turns on the BBC journalism derogation.
F v M & Ors
[2025] EWFC 433 (B) · 24 November 2025
A private prescription, non-collection of it and subsequent street-cannabis use are material to the court’s assessment of parenting risk.
Cheshire East Borough Council v Mother & Ors
[2025] EWFC 470 (B) · 29 July 2025
A short period of prescribed medicinal cannabis is considered within wider findings about cannabis use, mental health and parenting capacity.
DE v FG
[2025] EWHC 666 (Fam) · 20 March 2025
Prescribed liquid cannabis is considered within a longer history of cannabis use and the welfare assessment.
Louisa Mojela v Canmart Ltd & Anor
[2023] EWHC 2668 (Ch) · 30 October 2023
The parties operate in the medical-cannabis industry, though the legal dispute concerns company and commercial matters.
GW Pharma Limited & Anor v Otsuka Pharmaceutical Co, Limited
[2022] EWCA Civ 1462 · 8 November 2022
The appeal concerns patent jurisdiction arising from Epidyolex, a licensed cannabidiol medicine developed from cannabis-derived compounds.
Otsuka Pharmaceutical Co., Ltd v GW Pharma Limited & Anor.
[2022] EWHC 1012 (Pat) · 3 May 2022
Epidyolex, a licensed cannabidiol medicine for severe epilepsy syndromes, is central to a patent and royalty dispute.
Quayle & Ors v R
[2005] EWCA Crim 1415 · 27 May 2005
The appeals directly address whether medical necessity can defend cannabis cultivation, possession or importation.